How Big Is the Drug-Eluting Stent Market | Segmentation & Insights 2031

Q: What is the current size of the drug-eluting stent market?

The drug-eluting stent market was valued at USD 6.9 Billion in 2024 and is expected to reach USD 13.6 Billion by 2031

Q: What factors are accelerating the drug-eluting stent market growth?

Key factors include rising cardiovascular disease burden, advancements in polymer technologies, and a surge in minimally invasive angioplasty procedures.

Q: Which regions are seeing the fastest growth in DES adoption?

Asia-Pacific and Latin America are seeing rapid growth due to expanding healthcare access and increasing government cardiovascular health initiatives.

Q: What role does AI play in the drug-eluting stent market?

AI is being integrated into surgical navigation systems to improve precision during stent placement and predict patient outcomes, enhancing procedural success.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6183

Publication Date: Jul 2025

How Big Is the Drug-Eluting Stent Market?

According to 6Wresearch internal database and industry insights, the Global Drug-Eluting Stent (DES) Market was valued at USD 6.9 Billion in 2024 and is expected to reach USD 13.6 Billion by 2031, growing at a compound annual growth rate of 10.59% during the forecast period (2025-2031).

This growth is proliferated by the rising prevalence of coronary artery disease, increasing adoption of minimally invasive procedures, and technological advancements in bioresorbable and polymer-free DES designs.

View Main Report

Schedule Analyst Call

Growth Factors of the Drug-Eluting Stent Market

Growing geriatric population prone to cardiovascular complications
Technological innovation in stent platforms including biodegradable coatings
Increased adoption of minimally invasive cardiac interventions over open surgeries
Rising lifestyle-related conditions like obesity and diabetes driving coronary complications
Government support and public health initiatives for cardiovascular treatment access
Expanding healthcare infrastructure and diagnostic access in emerging markets

Drug-Eluting Stent Market Trends

Drug-Eluting Stent Market is witnessing a shift toward next-generation stents featuring thinner struts, polymer-free drug coatings, and better biocompatibility. Hospitals and clinics are increasingly preferring DES over bare-metal stents due to lower restenosis rates. There is also a growing preference for customized stent solutions based on patient-specific anatomy and comorbidities. Furthermore, with increasing clinical trials supporting the long-term efficacy of newer stent technologies, their adoption is expanding globally.

Emerging Developments in Drug-Eluting Stent Market

Emerging innovations in the Drug-Eluting Stent Market include the development of fully bioresorbable scaffolds, dual therapy stents, and AI-assisted deployment techniques to optimize placement. Research collaborations are enhancing the durability of drug coatings, while start-ups and med-tech giants are investing in 3D-printed stent prototypes for precision cardiovascular care.